Key Bridge Compliance, LLC Citius Pharmaceuticals, Inc. Transaction History
Key Bridge Compliance, LLC
- $319 Billion
- Q3 2023
A detailed history of Key Bridge Compliance, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Key Bridge Compliance, LLC holds 154,130 shares of CTXR stock, worth $26,202. This represents 0.03% of its overall portfolio holdings.
Number of Shares
154,130Holding current value
$26,202% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
60Shares Held
23.7MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$1.24 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$319,4220.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$306,9730.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$196,9460.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $24.8M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...